Muhammad Beg, MD
Medical Oncology · Boise, IDNPI 1508077298
Payments from drug & device makers
Across 280 payments — averaging $19,358 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$3.7M
- AstraZeneca$515K
- Grifols Therapeutics LLC$424K
- E.r. Squibb & Sons, L.L.C.$315K
- Incyte Corporation$176K
- Agios Pharmaceuticals, Inc.$94K
- plus $218K from 11 others
Across 2 payments — averaging $22,212 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AVEO Pharmaceuticals, Inc.$44K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 47 | $3,678,383 |
| AstraZeneca | 64 | $514,603 |
| Grifols Therapeutics LLC | 13 | $424,430 |
| E.r. Squibb & Sons, L.L.C. | 11 | $314,523 |
| Incyte Corporation | 56 | $175,712 |
| Agios Pharmaceuticals, Inc. | 35 | $94,493 |
| Foundation Medicine, Inc. | 17 | $54,440 |
| QED Therapeutics, Inc. | 10 | $48,955 |
| Gilead | 5 | $44,820 |
| Eli Lilly | 2 | $24,772 |
| Bristol Myers Squibb | 3 | $17,772 |
| Ipsen Biopharmaceuticals, Inc | 10 | $13,767 |
| Servier Pharmaceuticals LLC | 1 | $5,070 |
| Astrazeneca UK Limited | 2 | $3,425 |
| Sirtex Medical Inc | 2 | $2,635 |
| Array Biopharma Inc | 1 | $2,361 |
| Genentech USA, Inc. | 1 | $111 |
How this compares
Too few medical oncology providers in Idahoto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other medical oncology in Boise
- Jashmin PatelBoise$20K
- Cannon MilaniBoise$9K
- Norman ZuckermanBoise$51
- Silvana BucurMeridian$192K
- Peyman HaghighatMeridian$114K
- Travis WilliamsMeridian$50K
- Leila KhaddourCaldwell$20K
- Jonathan SwerdloffNampa$18K
- Sushma PantLewiston$8K
- Gerardo MidenceLewiston$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.